Dr. Sudha Sinha

Medical Degrees

• MBBS — Gandhi Medical College, University of Health Sciences, Hyderabad, India, 1996
• Internship in Internal Medicine — St. Barnabas Medical Center Livingston, NJ, USA (1998–1999)
• Residency in Internal Medicine — St. Barnabas Medical Center Livingston, NJ, USA (1999–2001)
• Diplomate — American Board of Internal Medicine, 2001

Fellowships & Special Training

• Fellowship in Hematology and Oncology — Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA (2002–2005)
• Chief Fellow, Division of Hematology/Oncology — Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA (2004–2005)
• Research Fellow at the Center for Cell Biology, St. Elizabeth's Medical Center, USA (July 2003 – June 2004)
• Specialised training in expression and purification of erythrocyte macrophage protein
• Specialised training in cysteine protease inhibitors as anti-malarial drugs
• Specialised training in molecular mechanisms of erythroblast-macrophage interactions
• Junior Investigator Award — 26th Annual Meeting of American Society of Apheresis, 2005
• Resident Research Scholarship Award — St. Barnabas Medical Center, 2001

Certifications & Accreditations

• Triple US Board Certifications — American Board of Oncology, American Board of Hematology, and American Board of Internal Medicine
• Telangana State Medical Council — Registered
• Andhra Pradesh Medical Council — Registered
• National Medical Commission / Medical Council of India Registration
• Diplomate — American Board of Internal Medicine, 2001
• Member — European Society of Medical Oncology (ESMO)
• Member — Indian Medical Association (IMA)

Major Conditions Treated

• Breast Cancer
• Cervical Cancer
• Ovarian Cancer
• Endometrial Cancer
• Gestational Trophoblastic Diseases
• Acute Myeloid Leukaemia (AML)
• Acute Lymphoblastic Leukaemia (ALL)
• Chronic Myeloid Leukaemia (CML)
• Lymphoma (Hodgkin and Non-Hodgkin)
• Multiple Myeloma
• Lung Cancer
• Liver Cancer
• Oral Cancer
• Throat Cancer
• Acute Promyelocytic Leukaemia (APML)
• Pediatric Cancers

Sub-specialties

• Women's Cancers Oncology: Specialist in breast, cervix, ovary, endometrium cancer treatment — establishes her as a trusted medical oncologist specialist in Hyderabad, India.
• Curable Haematological Malignancies: Specialist in leukaemia, lymphoma, multiple myeloma — for international patients seeking best medical oncology care in India.
• Gestational Trophoblastic Diseases: Specialist in this rare gynaecological cancer.
• Pediatric Oncology: Established the largest pediatric oncology programme in South India at MNJ Institute.
• Cancer Care for Underserved Populations: Founder of IMPACT, a free cancer centre for children who cannot afford treatment.
• Targeted Therapy & Immunotherapy: Specialist in modern systemic cancer therapies.

Advanced Procedures & Treatments

• Chemotherapy (IV & Oral Regimens)
• Targeted Therapy (HER2, BRCA, EGFR, ALK inhibitors)
• Immunotherapy / Checkpoint Inhibitors (PD-1, PD-L1)
• Hormone Therapy (Breast, Endometrial Cancer)
• Pediatric Cancer Chemotherapy
• Multidisciplinary Tumour Board Coordination
• Cancer Screening & Awareness Programmes
• Peripheral Blood Progenitor Cell Mobilization
• PICC Line Placement & Repair
• Tumour Marker Monitoring & Molecular Profiling
• Bone Marrow Aspiration and Biopsy
• Rasburicase Therapy for Hyperuricemia
• Palliative Care Coordination
• Adjuvant and Neoadjuvant Chemotherapy
• Maintenance Therapy

Current Affiliation

• Yashoda Hospitals, Hyderabad — Clinical Director, Medical Oncology, Present
• CARE Hospitals, HITEC City, Hyderabad — Clinical Director, Oncology Services and Head of Department, Medical Oncology (recent past role)

Past Affiliations

• American Oncology Institute, Hyderabad — Senior Consultant Medical Oncologist (2018–2020)
• Continental Hospitals, Hyderabad — Senior Consultant in Hematology and Oncology (2014–2017)
• MNJ Institute of Oncology & Regional Cancer Centre, Lakdi Ka Pul, Hyderabad — Assistant Professor and Head of Department of Medical Oncology (2007–2017)
• Fernandez Hospital, Hyderguda, Hyderabad — Consultant Medical Oncologist (Past)
• Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA — Chief Fellow Hematology/Oncology (2004–2005)
• Caritas St. Elizabeth's Medical Center — Hematology and Oncology Fellow (2002–2005)
• St. Elizabeth's Medical Center, USA — Research Fellow at Center for Cell Biology (2003–2004)
• St. Barnabas Medical Center Livingston, NJ, USA — Resident in Internal Medicine (1999–2001)
• St. Barnabas Medical Center Livingston, NJ, USA — Intern in Internal Medicine (1998–1999)
• Gandhi Medical College, University of Health Sciences, Hyderabad — MBBS (Past)

Academic & Research Roles

• Clinical Director — Medical Oncology, Yashoda Hospitals, Hyderabad
• Past Head of Medical Oncology at MNJ Institute of Oncology & Regional Cancer Centre (10 years)
• Established 60-bed adult leukemia programme at MNJ
• Established 80-bed pediatric oncology programme at MNJ — largest in South India
• Founder — IMPACT, a free cancer centre for children (impactchild.org)
• Initiated ICMR (Indian Council of Medical Research) Funded Hospital Based National Cancer Registry Programme
• Key role in expanding the Biochemistry, Microbiology and Pathology Labs at MNJ
• 30+ publications in international medical journals
• Member — European Society of Medical Oncology (ESMO), Indian Medical Association (IMA)
• Multilingual: Telugu, Hindi, English

Key Achievements

• 20+ years of clinical experience across USA and India
• Triple US Board Certifications — American Board of Oncology, American Board of Hematology, American Board of Internal Medicine
• Tufts University School of Medicine fellowship and chief fellowship
• Past Head of Medical Oncology at MNJ Institute of Oncology & Regional Cancer Centre for 10 years (2007–2017)
• Established the largest pediatric oncology programme in South India
• Founder of IMPACT — free cancer centre for children
• 30+ publications in international medical journals
• Recognised by FICCI, Civil Society, and Rotary for cancer care work
• Junior Investigator Award — American Society of Apheresis, 2005
• Civil Society Hall of Fame Award, New Delhi, 2015
• Felicitation by Ladies Circle India, 2015
• Young FICCI Ladies Organisation — Felicitation for Young Women Achievers Building India, March 2012
• Rotary Club of Bhagyanagar Vocational Excellence Award, 2012
• Rotary Club of Secunderabad Award of Recognition, 2012
• Unsung Heroines of Hyderabad — Recognition by Secunderabad Metropolitan Ladies Circle, 49 in 2014

National & International Awards

• Civil Society Hall of Fame Award, New Delhi, 2015
• Felicitation by Ladies Circle India, 2015
• Unsung Heroines of Hyderabad — Recognition by Secunderabad Metropolitan Ladies Circle, 49 in 2014
• Young FICCI Ladies Organisation — Felicitation for Young Women Achievers Building India, March 2012
• Rotary Club of Bhagyanagar Vocational Excellence Award, 2012
• Rotary Club of Secunderabad Award of Recognition, 2012
• Junior Investigator Award — 26th Annual Meeting of American Society of Apheresis, 2005
• Resident Research Scholarship Award — St. Barnabas Medical Center, 2001

Professional Memberships

• European Society of Medical Oncology (ESMO) — Member
• Indian Medical Association (IMA) — Member
• American Board of Oncology — Diplomate
• American Board of Hematology — Diplomate
• American Board of Internal Medicine — Diplomate
• American Society of Hematology (ASH) — Member
• American Society of Apheresis (ASFA) — Member
• Telangana State Medical Council — Registered
• National Medical Commission / Medical Council of India — Registered

Published Papers (Selected)

• Digumarti R, Sinha S, Nirni SS, Patil SG, Pedapenki RM. "Efficacy of Rasburicase in the Prevention and Treatment of Malignancy Associated Hyperuricemia – an Indian Experience." Indian J Cancer. 2014 Apr–Jun; 51(2):180–3.
• Cingeetham A, Vuree S, Jiwatani S, Kagita S, Dunna NR, Meka PB, Gorre M, Annamaneni S, Digumarti R, Sinha S, Satti V. "Role of the MDM2 Promoter Polymorphism in Acute Myeloid Leukemia Development." Asian Pac J Cancer Prev. 2015; 16(7):2707–12.
• Cingeetham A, Vuree S, Dunna NR, Gorre M, Nanchari SR, Edathara PM, Mekkaw P, Annamaneni S, Digumarthi RR, Sinha S, Satti V. "Association of Caspase9 Promoter Polymorphisms with the Susceptibility of AML in South Indian Subjects." Tumour Biol. 2014 Sep; 35(9):8813–22.
• Chiranjeevi P, Spurthi KM, Rani NS, Kumar GR, Aiyengar TM, Saraswati M, Srilatha G, Kumar GK, Sinha S, Kumari CS, Reddy BN, Vishnupriya S, Rani HS. "Gelatinase B (-1562C/T) Polymorphism in Tumor Progression and Invasion of Breast Cancer." Tumour Biol. 2013 Dec 20.
• Anuradha V, Anand BB, Suresh AV, Sinha S, Babu SC, Suresh K. "Palliative Chemotherapy in Head and Neck Squamous Cell Cancer." Indian J Med Paediatr Oncol.
• Sinha S, Poh KK, Sodano D, Flanagan J, Ouilette C, Kearney M, Heyd L, Wollins J, Losordo D, Weinstein R. "Safety and Efficacy of Peripheral Blood Progenitor Cell Mobilization and Collection in Patients with Advanced Coronary Heart Disease." J Clin Apher. 2006 Jul; 21(2):116–20.
• Bala S, Kumar A, Soni S, Sinha S, Hanspal M. "A Component of the Nuclear Matrix of Mammalian Cells and Undergoes Dynamic Rearrangements During Cell Division." Biochem Biophys Res Commun. 2006 Apr 21; 342(4):1040–8.
• "Health Related Quality of Life Among Children with Cancer in Hyderabad, India." 2009 Dec; 76(12):1231.

Ongoing Research & Clinical Interests

• Women's cancers (breast, cervix, ovary, endometrium)
• Acute myeloid leukaemia (AML) and genetic polymorphisms
• Acute promyelocytic leukaemia (APML) treatment optimisation
• Pediatric oncology programme development
• Gestational trophoblastic disease
• Quality of life in pediatric cancer patients
• Gelatinase B polymorphism in breast cancer
• Rasburicase efficacy in hyperuricemia
• Palliative chemotherapy in head & neck squamous cell carcinoma

*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.